Showing results (1301-1310 of 1,376) with videos related to
Sort By:
Pageof 138
Bioorganic & Medicinal Chemistry Letters|February 22, 2014
Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like propertiesDong Xiao, Xiaohong Zhu, Younong Yu, et al.Molecular Cell|August 28, 2021
Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunityFansen Meng, Zhengyang Yu, Dan Zhang, et al.Nature Communications|September 27, 2019
Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24Tao Yu, Shucheng Gan, Qingchen Zhu, et al.Nature Immunology|March 23, 2018
IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signalingTomasz Herjan, Lingzi Hong, Jodi Bubenik, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemiaJun Qin, Ashwin Rao, Xiao Chen, et al.Theranostics|October 24, 2022
Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative stateXu Yang, Guilin Li, Yuhua Tian, et al.Science Translational Medicine|June 11, 2025
Proteogenomic characterization reveals that lipid droplet formation promotes esophageal squamous cell cancer progressionZhaoyu Qin, Dongxian Jiang, Zihan Yu, et al.Cancer Cell|February 13, 2026
Chemotherapy triggers immune evasion by fostering LEPR+ Kupffer cell differentiation in liver metastasesXuege Wang, Qiang Pan, Yaqi Li, et al.Plant Physiology|November 3, 2018
Recursive Paleohexaploidization Shaped the Durian GenomeJinpeng Wang, Jiaqing Yuan, Jigao Yu, et al.Cancer Cell|April 25, 2025
KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapyJiacheng Guo, Ni Li, Qiuli Liu, et al.Pageof 138